RCM
PRAX icon

RA Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

RA Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-373,787
Closed -$120M – 90
2026
Q1 		$120M Hold
373,787
– – 1.28% 18
2025
Q4 		$110M Buy
+373,787
New +$69.6M 1.13% 21
2025
Q1 		– Sell
-761,955
Closed -$58.6M – 94
2024
Q4 		$58.6M Hold
761,955
– – 0.78% 27
2024
Q3 		$43.8M Sell
761,955
-473,644
-38% -$25.6M 0.51% 41
2024
Q2 		$51.1M Buy
1,235,599
+407,219
+49% +$19.2M 0.68% 37
2024
Q1 		$50.5M Buy
+828,380
New +$37.2M 0.64% 41

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RA Capital Management's PRAX Position: Q2 2026 in Review

RA Capital Management sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 373,787 shares — an estimated $120M sold.

RA Capital Management first reported a position in PRAX in Q1 2024 and held it in 6 quarters. The position peaked at $120M in Q1 2026. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • RA Capital Management reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • RA Capital Management sold 373,787 Praxis Precision Medicines shares in Q2 2026, an estimated $120M.
  • RA Capital Management first reported a position in Praxis Precision Medicines in Q1 2024 and held it in 6 quarters.
  • RA Capital Management's Praxis Precision Medicines position peaked at $120M in Q1 2026.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on RA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.